EDEL ALVAREZ GALBAN: Open Payments
NPI 1477930501 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 7 payments from 6 companies in 2025. Trend: 2023 $877 · 2024 $272 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Novo Nordisk Inc | 1 | $118 |
| INTUITIVE SURGICAL, INC. | 1 | $109 |
| Lilly USA, LLC | 2 | $57 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: REXULTI, Ozempic, Da Vinci Surgical System, MOUNJARO, TRELEGY ELLIPTA, KEVEYIS.
Industry payments across FL — which companies pay providers there.
